CIK 0000818686 · Large accelerated filer
TEVA PHARMACEUTICAL INDUSTRIES LTD
Sign in to watch- Ticker
- TEVA
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- operating
- Phone
- 972 (3) 914-8213
- Business address
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $33,923,078
- in 11 filings, $11.2M under 10b5-1 plans
Net −$33,923,078. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | Francis Richard D President and CEO | Option exercise · Restricted Share Units 10b5-1 | −42,452 | 127,359 | ||
| 2026-03-05 | Fox Christine EVP, U.S. Commercial | Option exercise 10b5-1 | +17,819 | 92,829 | ||
| 2026-03-05 | Fox Christine EVP, U.S. Commercial | Sale 10b5-1 | −7,924 | $31.67 | $251K | 84,905 |
| 2026-03-05 | Fox Christine EVP, U.S. Commercial | Option exercise · Restricted Share Units 10b5-1 | −17,819 | 53,459 | ||
| 2026-03-05 | Hughes Eric A See "Remarks" | Option exercise 10b5-1 | +19,654 | 117,244 | ||
| 2026-03-05 | Hughes Eric A See "Remarks" | Sale 10b5-1 | −9,533 | $31.67 | $302K | 107,711 |
| 2026-03-05 | Hughes Eric A See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −19,654 | 58,962 | ||
| 2026-03-05 | Daniell Richard EVP, Europe Commercial | Option exercise 10b5-1 | +17,295 | 103,050 | ||
| 2026-03-05 | Daniell Richard EVP, Europe Commercial | Sale 10b5-1 | −17,295 | $31.67 | $548K | 85,755 |
| 2026-03-05 | Daniell Richard EVP, Europe Commercial | Option exercise · Restricted Share Units 10b5-1 | −17,295 | 51,887 | ||
| 2026-03-05 | Jover Placid See "Remarks" | Option exercise 10b5-1 | +14,150 | 20,924 | ||
| 2026-03-05 | Jover Placid See "Remarks" | Sale 10b5-1 | −14,150 | $31.67 | $448K | 6,774 |
| 2026-03-05 | Jover Placid See "Remarks" | Option exercise · Restricted Share Units 10b5-1 | −14,150 | 42,453 | ||
| 2026-03-05 | Savage Brian Interim Chief Legal Officer | Option exercise | +3,580 | 12,041 | ||
| 2026-03-05 | Savage Brian Interim Chief Legal Officer | Sale | −1,127 | $31.67 | $36K | 10,914 |
| 2026-03-05 | Savage Brian Interim Chief Legal Officer | Option exercise · Restricted Share Units | −3,580 | 10,740 | ||
| 2026-03-05 | Shields Matthew EVP, Global Operations | Option exercise 10b5-1 | +17,295 | 27,284 | ||
| 2026-03-05 | Shields Matthew EVP, Global Operations | Sale 10b5-1 | −17,295 | $31.67 | $548K | 9,989 |
| 2026-03-05 | Shields Matthew EVP, Global Operations | Option exercise · Restricted Share Units 10b5-1 | −17,295 | 51,887 | ||
| 2026-03-04 | Francis Richard D President and CEO | Option exercise 10b5-1 | +50,223 | 1,171,605 |
Page 6 of 64 · 1,279 trades